These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10634001)

  • 21. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
    Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
    Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor V Leiden mutation in postthrombotic and non-postthrombotic venous ulcers.
    Hafner J; Kühne A; Schär B; Bombeli T; Hauser M; Lüthi R; Hänseler E
    Arch Dermatol; 2001 May; 137(5):599-603. PubMed ID: 11346337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients.
    Altinisik J; Ates O; Ulutin T; Cengiz M; Buyru N
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):415-20. PubMed ID: 18160601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of activated protein C resistance (Factor V Leiden) in Lagos, Nigeria.
    Adeyemo TA; Adediran A; Akinbami AA; Akanmu AS
    Niger J Clin Pract; 2012; 15(2):136-41. PubMed ID: 22718159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
    Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
    Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
    Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
    Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of factor V Leiden mutations on prognosis in patients with acute myocardial infarction].
    Baykan M; Celik S; Uçar F; Kaplan S; Ovali E; Erdöl C
    Anadolu Kardiyol Derg; 2001 Dec; 1(4):242-5; AXIV. PubMed ID: 12101832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
    Chaireti R; Jennersjö C; Lindahl TL
    Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
    Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
    Kabukcu S; Keskin N; Keskin A; Atalay E
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of factor V Leiden in a population of patients with congenital heart disease.
    Ong BC; Zimmerman AA; Zappulla DC; Neufeld EJ; Burrows FA
    Can J Anaesth; 1998 Dec; 45(12):1176-80. PubMed ID: 10051935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of resistance to activated protein C in myocardial infarction patients].
    Avellone G; Di Garbo V; Di Raimondo D; Bono M; Abruzzese G; De Simone R; Raneli G
    Minerva Cardioangiol; 2001 Dec; 49(6):363-8. PubMed ID: 11733730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor V Leiden in patients with venous thrombosis in Slovak population.
    Simkova M; Batorova A; Dostalova K; Pozgayova S; Simko F; Kovacs L
    Gen Physiol Biophys; 2004 Dec; 23(4):435-42. PubMed ID: 15815078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American population.
    Bavikatty NR; Killeen AA; Akel N; Normolle D; Schmaier AH
    Am J Clin Pathol; 2000 Aug; 114(2):272-5. PubMed ID: 10941343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombophilia in cardiac surgery-patients with symptomatic factor V Leiden.
    Massoudy P; Thielmann M; Müller-Beissenhirtz H; Görlinger K; Dietrich W; Herget-Rosenthal S; Jakob H
    J Card Surg; 2009; 24(4):379-82. PubMed ID: 19040405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile.
    Margaglione M; Bossone A; Coalizzo D; D'Andrea G; Brancaccio V; Ciampa A; Grandone E; Di MG
    Thromb Haemost; 2002 Jan; 87(1):32-6. PubMed ID: 11848454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ABO/H blood groups and factor V Leiden].
    Matýsková M; Zavrelová J; Pejchalová A; Meluzinová H; Janků L
    Cas Lek Cesk; 2002 Mar; 141(5):146-51. PubMed ID: 11998221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.